Magnus Financial Group LLC Emergent Bio Solutions Inc. Transaction History

Magnus Financial Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 05, 2020	SELL	$81.91 - $134.94 $345,168 - $568,637	-4,214 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$54.33 - $89.52 $228,946 - $377,237	4,214 New	4,214 $333,000
Q1 2019 May 09, 2019	SELL	$48.23 - $66.16 $214,285 - $293,948	-4,443 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$55.63 - $73.24 $247,164 - $325,405	4,443 New	4,443 $263,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Magnus Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Magnus Financial Group LLC with notifications on news.